Crux Biolabs operates a laboratory for vaccines, immunotherapies, immuno-oncology, and infectious diseases. The firm conducts specialist immunology contract research services for pre-clinical and clinical studies, as well as academic and biotech R&D, through its NATA accredited facility in Melbourne.
With an unrelenting drive and a singular focus on cellular therapy, Creative Biolabs is executing on our strategy to provide a broad range of CAR products and kits for hematologic malignancies and solid tumors...
Molecular cloning techniques makes it possible to engineer phage to carry a specific reporter gene, which provides an efficient alternative to native, unaltered phage particles for bacterial detection. Creative Biolabs is a biotechnology company who has rich experience in providing high-quality service in report phage engineering. We offer one-stop solutions to support you in all aspects of...
Skin care products, ageless healthy skin, biolabs skin creme, resveratrol anti aging cream, anti aging cream, resvmax, ageless, american top anti aging supplements, anti aging supplements, best skin care product, Resveratrol, beauty care.
Creative Biolabs is the leading antibodies provider that has extensive experience in various antibody production and engineering fields. Our antibodies can be used in a range of research areas.
Since PTMs are generally present in very low abundance, specific enrichment procedures are required before PTMs identification. MtoZ Biolabs has established a powerful and professional PTMs analysis platform, which includes Thermo Fisher Q ExactiveHF and Obitrap Fusion Lumos mass analyzer system, coupled with Nano-LC system. Our aim is to provide the most professional support for our clients'...
Flow cytometry enables the detection and quantification markers on immune cells. Crux Biolab's flow cytometry services are performed on CytoFLEX Platform instruments with up to 21 colours.
Recombinant Humanized (from mouse) antibody to Human PDCD1. It is a drug that targets the programmed cell death 1 (PD-1) receptor. The drug is intended for use in treating metastatic melanoma.
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
Recombinant monoclonal antibody to IL-6. Siltuximab (INN) (also known as CNTO 328, Anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease, among other types of cancer.